Source: Annual Congress 2004 - Clinical and diagnostic features of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kitada, R. Maekura, Y. Nishiuchi, M. Kobayashi, M. Ito (Toyonaka, Japan). The utility of a serodiagnosis for mycobacterium avium complex pulmonary disease diagnosed by the single available bronchial wash. Eur Respir J 2004; 24: Suppl. 48, 1313

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by mycobacterium avium-intracellulare complex (MAC) infection Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005 Clinical features of pulmonary Mycobacterium avium intracellulare complex disease with a solitary pulmonary nodule in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 687s Year: 2005 Mycobacterium tuberculosis DNA detection in urine samples from pulmonary tuberculosis patients Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Clinical relevance of Mycobacterium simiae in pulmonary samples Source: Eur Respir J 2008; 31: 106-109 Year: 2008 Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Incidence of mycobacterium tuberculosis in patients with bronchial anthracofibrosis Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Pulmonary aspergilloma complicated by a cavitary lesion caused by pulmonary Mycobacterium avium complex disease Source: Eur Respir J 2005; 26: Suppl. 49, 689s Year: 2005 FluoroType MTB system for the detection of pulmonary tuberculosis Source: ERJ Open Res, 3 (2) 00113-2016; 10.1183/23120541.00113-2016 Year: 2017 Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA Source: Eur Respir J 2013; 42: 454-460 Year: 2013 Clinical analysis of pulmonary Mycobacterium kansasii disease Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Clinical study of mycobacterium avium complex pulmonary disease complicated by interstitial pneumonia Source: Annual Congress 2011 - Non-tuberculous mycobacteria pulmonary infections Year: 2011 A case of familial pulmonary Mycobacterium avium complex disease – experience in Japan Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis Source: Eur Respir J 2015; 46: 707-716 Year: 2015 Pulmonary tuberculosis relapse or atypical mycobacterium infection? Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012